Meetings - The ASCO Post

This is Part 3 of Evolving Treatment Landscape of Indolent Lymphoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Laurie Sehn...

lymphoma

/ Evolving Treatment Landscape of Indolent Lymphoma

Case 2: Third-Line Treatment of Relapsed/Refractory Follicular Lymphoma

This is Part 2 of Evolving Treatment Landscape of Indolent Lymphoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Laurie Sehn...

lymphoma

/ Evolving Treatment Landscape of Indolent Lymphoma

Case 1: Second-Line Treatment of Early Relapsing Follicular Lymphoma

This is Part 1 of Evolving Treatment Landscape of Indolent Lymphoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Laurie Sehn...

Evolving Treatment Landscape of Indolent Lymphoma

Case 3: Relapsed/Refractory Nodal Marginal Zone Lymphoma

Case 2: Third-Line Treatment of Relapsed/Refractory Follicular Lymphoma

Case 1: Second-Line Treatment of Early Relapsing Follicular Lymphoma

Parker Institute for Cancer Immunotherapy Names New CEO

FDA Expands Indication for Lu 177 Vipivotide Tetraxetan in mCRPC

FDA Approves Perioperative Durvalumab for Muscle-Invasive Bladder Cancer

Tobacco Control May Have Prevented Millions of Premature Lung Cancer Deaths in United States

Neoadjuvant Nivolumab Plus Chemotherapy and Response-Stratified CRT in HPV-Negative Head and Neck Cancer